David Molyneux, a professor at the the Liverpool School of Tropical Medicine, Liverpool, England, outlines how priorities on dealing with the big 3 infectious diseases -- HIV/AIDS, tuberculosis, and malaria -- is obstructing public health initiatives to tackle preventable diseases such as the viral, bacterial, and parasitic infections of the tropics, and acute respiratory infections and diarrheal diseases of children. Examples are given of numerous cost-effective treatment programs for diseases such as onchocerciasis (river blindness) and Chagas disease.
Molyneux comments, The emphasis on the 'Big Three' killers and the derogatory assignment to the category of other diseases of those that can so easily be controlled or even eliminated, neglects the proven success of a range of interventions. An investment of a fraction of the annual requirements of the global fund would bring long-lasting benefit to the millions that still remain disabled, reduce morbidity, and prevent disablement in future generations. If we are to ensure the efficient use of the substantial resources needed to reduce morbidity and mortality associated with HIV/AIDS, tuberculosis, and malaria, then a small investment in proven, cost-effective interventions against other diseases -- preferably from the global fund resources -- will bring sustainable public-health benefits, integrate well with and strengthen the health system, reduce disabling conditions, and bring collateral benefits to the health of the poorest nations.
He concludes, Policy makers are ignoring scientific and operational evidence that interventions against other diseases are effective. By concentrating on so few agents, current policies could perpetuate inequity, disrupt health financing policies, divert human resources from achievable goals, and deny opportunities for impoverished health systems to improve. Current policy also raises ethical issues. Resources are being transferred to interventions against the 'Big Three' that, realistically, have only a limited chance of success as they are reactive and do not adequately control transmission -- a pre-requisite for any public-health impact.
Source: Liverpool School of Tropical Medicine
Second Strain of Bird Flu Found in US Dairy Cows: What It Means for Infection Prevention and Control
February 7th 2025A new H5N1 strain was found in Nevada dairy cows, challenging earlier transmission theories. This raises concerns about animal vulnerability, human health risks, and food safety. Experts emphasize the need for improved surveillance, biosecurity, and cross-sector collaboration to contain the virus spread.
Fungal Infections: The Silent Epidemic Threatening Global Health
February 6th 2025Fungal infections are a rising global threat, with antifungal resistance complicating treatment. Neil J. Clancy, MD, emphasizes the urgent need for research, better diagnostics, and stronger infection prevention strategies.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
Clean Hospitals With Alexandra Peters, PhD: The Double-Edged Sword of High-Tech
January 30th 2025Despite revolutionary advancements like alcohol-based hand rubs, infection prevention still faces major hurdles. Poor adherence to hygiene, overreliance on technology, and understaffed environmental services create perfect storm conditions for deadly outbreaks.